PET imaging study for adults with solid tumors
Part of Cancer clinical trials.
This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a confirmed solid tumor (diagnosed by biopsy, cytology, or clinical findings).
- You are already scheduled for a standard FDG PET scan.
- You are in good general health (able to perform daily activities, with no major health problems).
- If you can become pregnant, you must have a negative pregnancy test before the scan and agree to use effective birth control during the study and for 6 months after.
- You are not pregnant, breastfeeding, or allergic to gallium-based imaging agents or ethanol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of imaging agent (called a tracer) that helps PET scans see tumors more clearly. It may help doctors find and monitor cancer better.
This study tests a new PET scan tracer that aims to highlight cancer cells more clearly. If you join, you'll receive one injection of the tracer and then have a PET/CT scan to help your doctor see whether you have cancer or where it is.
This trial tests a new radioactive tracer called ELI421 to see how well it works for PET imaging in people with prostate cancer. It may help doctors find cancer more clearly.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It could help diagnose cancer or check if it has returned after treatment.
This trial tests an experimental PET imaging drug, called 68Ga-GP-01, to see if it can help show tumors and any spread of the cancer. The study will give you the imaging drug, then take a PET/CT scan. You may join if you have a solid tumor and are scheduled for surgery or a laparoscopic exploration to confirm the cancer.
This trial uses a special PET scan to take pictures of certain solid tumors. The scan uses a new dye that may help doctors see the tumors more clearly. You may be eligible if you have one of the listed cancers and are between 18 and 75 years old with good daily function.
Hear when a new Malignant Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.